Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies

Lupus

Volumn 16, Issue 7, 2007, Pages 479-482

  Castellino, Gabriella ^a   Corallini, F ^a   Trotta, F ^a   Secchiero, P ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Autoantibodies; Cytokines (TRAIL, osteoprotegerin); ELISA; SLE

Indexed keywords

LA ANTIBODY; OSTEOPROTEGERIN; RO ANTIBODY; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 34547781247     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307079455     Document Type: Article

References (17)

1. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 2005; 4: 189-194.
2. White S, Rosen A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 2003; 5: 557-562.
3. Famularo G, Nucera E, Marcellini S, De Simone C. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation. Med Hypotheses 1999; 53: 50-62.
4. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Cell Immunol 2006; 239: 121-128.
5. Rus V, Atamas SP, Shustova V et al. Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol 2002; 102: 283-290.
6. Kaplan MJ, Lewis EE, Shelden EA et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologus lupus T cells. J Immunol 2002; 169: 6020-6029.
7. Lub-de Hooge MN, De Vries EGE, de Jong S, Bijl M. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 854-858.
8. Zauli G, Secchiero P. The role of the TRAIL/TRAIL receptors system in hemopoiesis and endothelial cell biology. Cytokine & Growth Factor Reviews 2006; 17: 245-257.
9. Ziolkowska M, Kurowska M, Radzikowska A et al. High levels of osteoprotegerin and soluble receptor activator of Nuclear Factor kB ligand in serum of rheumatoid arthritis patients and their normalization after antitumor necrosis factor α treatment. Arthritis Rheum 2002; 46: 1744-1753.
10. Choi JW. Relationships between tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) and hematopoietic activity in healthy adults. Ann Hematol 2005; 84: 728-733.
11. Liabbakk NB, Espevik T. Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. J Immunol Methods 2002; 259: 119-128.
12. Matsuyama W, Yamamoto M, Higashimoto I et al. TNF-related apoptosis inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood 2004; 104: 184-191.
13. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993; 2: 15-19.
14. Cretney E, Shanker A, Yagita H, Smyth MJ, Sayers TJ. TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer. Immunol Cell Biol 2006; 84: 87-98.
15. Kurien BT, Newland J, Paczkowski C, Moore KL, Scofield RH. Association of neutropenia in systemic lupus erythematosus with anti-Ro and binding of an immunobiologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol 2000; 120: 209-217.
16. Hsieh SC, Yu HS, Lin WW et al. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 2003; 131: 396-397.
17. Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophilis by TNF-related apoptosis-inducing ligand. J Immunology 2005; 175: 1232-1238.